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Factors influencing time to diagnosis and
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Lymphoma among children in Uganda and
western Kenya: a cross-sectional survey
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Kristine Stiffler5, Corey Casper5, Juliana A Otieno6, Jackson Orem4 and Ann M Moormann7*
Abstract
Background: Survival rates for children diagnosed with Burkitt lymphoma (BL) in Africa are far below those
achieved in developed countries. Late stage of presentation contributes to poor prognosis, therefore this study
investigated factors leading to delays in BL diagnosis and treatment of children in Uganda and western Kenya.
Methods: Guardians of children diagnosed with BL were interviewed at the Jaramogi Oginga Odinga Teaching and
Referral Hospital (JTRH) and Uganda Cancer Institute (UCI) from Jan-Dec 2010. Information on sociodemographics,
knowledge, attitudes, illness perceptions, health-seeking behaviors and prior health encounters was collected using
a standardized, pre-tested questionnaire.
Results: Eighty-two guardians were interviewed (20 JTRH, 62 UCI). Median “total delay” (1st symptoms to BL
diagnosis) was 12.1 weeks [interquartile range (IQR) 4.9-19.9] in Kenya and 12.9 weeks (IQR 4.3-25.7) in Uganda. In
Kenya, median “guardian delay” (1st symptoms to 1st health encounter) and “health system delay” (1st health
encounter to BL diagnosis) were 9.0 weeks (IQR 3.6-15.7) and 2.0 weeks (IQR 1.6-5.8), respectively. Data on guardian
and health system delay in Uganda were only available for those with < 4 prior health encounters (n = 26). Of these,
median guardian delay was 4.3 weeks (range 0.7-149.9), health system delay 2.6 weeks (range 0.1-16.0), and total
delay 10.7 weeks (range 1.7-154.3). Guardians in Uganda reported more health encounters than those in Kenya
(median 5, range 3–16 vs. median 3, range 2–6). Among Kenyan guardians, source of income was the only
independent predictor of delay, whereas in Uganda, guardian delay was influenced by guardians’ beliefs on the
curability of cancer, health system delay, by guardians’ perceptions of cancer as a contagious disease, and total
delay, by the number of children in the household and guardians’ role as caretaker. Qualitative findings suggest
financial costs, transportation, and other household responsibilities were major barriers to care.
Conclusions: Delays from symptom onset to BL treatment were considerable given the rapid growth rate of this
cancer, with guardian delay constituting the majority of total delay in both settings. Future interventions should
aim to reduce structural barriers to care and increase awareness of BL in particular and cancer in general within the
community, as well as among health professionals.
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Background
Endemic Burkitt Lymphoma (BL) is the most common
childhood cancer in equatorial Africa and in other re-
gions with holoendemic malaria [1,2]. In these areas, BL
represents more than half of all childhood cancers and
up to 90% of all lymphomas [3]. A characteristic feature
of BL is its rapid doubling time (24 to 48 hours) and
high proliferation index (near 100%), which makes BL
highly susceptible to chemotherapy [4]. In high-income
(HIC) countries, where appropriate treatment and sup-
portive care are typically available, cure rates for BL ex-
ceed 90% [5,6]. However, survival rates for children with
BL receiving treatment in many parts of Africa remain far
lower. Most recent studies on the optimal management of
BL in this setting have reported cure rates ranging from
48 to 67% [7,8].
In equatorial Africa and other low-income settings, poor
outcomes of childhood cancers can be attributed to sev-
eral factors, including abandonment of therapy, scarcity
of medication and supplies for comprehensive care, nutri-
tional deficiencies, inaccurate diagnostics, and treatment-
related mortality. Another key cause of treatment failure
is late stage of presentation, underscoring the importance
of prompt diagnosis and early treatment. Among children
with BL, advanced stage has been shown to be associated
with poorer response to first-line therapy [9]. With few
second-line therapeutic options, late stage of presentation
is therefore believed to be a principal barrier to improving
long-term survival among children with BL in these
settings [10].
Reasons for delayed diagnosis of childhood cancers in
sub-Saharan Africa have been previously unexplored. The
objective of our study was to investigate the health-
seeking experiences of guardians of children specific to
BL because of its evident physical manifestations and to
identify factors that may lead to delays in these settings.
Results from this study may also be applicable to other
childhood cancers in Uganda and western Kenya.
Results
Sociodemographic characteristics of the guardians
A total of 82 guardians of children diagnosed with BL
were enrolled in our study: 62 at Uganda Cancer Institute
(UCI) and 20 at Jaramogi Oginga Odinga Teaching
and Referral Hospital (JTRH), (formerly the New Nyanza
Provincial General Hospital) in Kisumu, Kenya. Table 1
summarizes the sociodemographic characteristics of par-
ticipating guardians. In brief, the majority of respondents
were mothers of the child diagnosed with BL (Kenya 80%;
Uganda 50%) and self-identified as primary caretaker (Kenya
90%, Uganda 93%). Half or more worked as peasant farmers
(Kenya 50%, Uganda 68%) and the majority reported prior
education at primary level or below (Kenya 70%, Uganda
76%). The mean age of the guardian was 36 (range 22–60)
and 39 (range 22–65) years in Kenya and Uganda, respect-
ively. There were no significant differences in guardians’
sociodemographic characteristics between the two sites.
Onset of child’s illness: symptoms and guardian’s perceptions
Guardians in Kenya and Uganda recounted noticing simi-
lar symptoms at the onset of illness, which were largely
non-specific in their presentation. More than half of re-
spondents in both settings said painless swelling of the
neck, face, chest, abdomen, underarm or groin was present
when the child’s illness was first identified. Kenyan children
also commonly had experienced fever, fatigue, weight loss
or night sweats (80%), whereas bleeding gums or loose of
painful teeth were commonly observed among children in
Uganda (31%) with mandibular lesions.
Although early symptoms were mostly similar in both
settings, guardians’ initial perceptions of the illness var-
ied between the two sites. Twenty-six of the 62 guard-
ians (42%) in Uganda had suspected the illness was a
dental problem or cyst, 12 (19%) believed their child to
have a tumor, and 7 (11%) attributed the illness to an
injury. Notably, 3 guardians (5%) thought it was a curse or
witchcraft. Of the 20 guardians in Kenya, 7 (35%) initially
perceived the illness to be splenomegaly or abdominal
swelling (referred to as ‘hima’ in the Kenyan Luo language)
and 6 (30%) malaria. No Kenyan guardian initially suspected
cancer nor attributed their child’s illness to a curse or
witchcraft.
Length of delay
The median total delay as reported by guardians of
children with BL was 12.1 weeks (range 2.0-308.6) in
western Kenya and 12.9 weeks (range 1.7-154.3) in Uganda
(mean 38.3 weeks standard deviation 77.3, and 20.4 weeks
standard deviation 25.6, respectively). In Kenya, the median
guardian delay was greater than the median health system
delay at 9.0 (range 0–298.0) and 2.0 weeks (range 0.6-21.4)
respectively (mean 34.0 weeks standard deviation 75.8, vs.
4.3 weeks standard deviation 4.9). Unfortunately in Uganda,
data collected on the guardian delay and health system
delay were only available for those guardians with 3 or less
health encounters prior to UCI. The questionnaire was
designed to capture guardians’ responses to a series of
questions for each health encounter. In Uganda, there
was systematic error in data collection that resulted in,
after the fourth encounter, failure to document guardians’
responses to the question that assessed time between
health encounters. Other questions were unaffected. Among
this subgroup of guardians with 3 or less health encoun-
ters, total delay was slightly less than the overall Ugandan
cohort (median 10.7 weeks, mean 22.0 standard deviation
34.0). Analysis of the components of delay among this
subgroup showed that guardian delay also constituted
the majority of the total delay (guardian delay median
Buckle et al. Infectious Agents and Cancer 2013, 8:36 Page 2 of 16
http://www.infectagentscancer.com/content/8/1/36
4.3 weeks, range 0.7-149.9, vs. health system delay median
2.6 weeks, range 0.1-16.0; n = 26). Mean guardian delay was
16.9 weeks (standard deviation 34.1), while mean health
system delay was 5.1 weeks (standard deviation 5.0).
Care-seeking history
Guardians in Kenya most commonly visited dispensaries
when initially seeking care for their child (50% of respon-
dents). The next most common facilities for first node
of entry were community clinics, mobile clinics, and
mission hospitals, each reported by 10%. The remainder
of Kenyan guardians first visited a dental clinic, health
center (any level), district hospital or JTRH (5% each).
In Uganda, 48% of all guardians first sought help at
private clinics/hospitals, followed by health centers (any
level, 21%), and district hospitals and herbalists (8% each).
Seven percent visited a regional hospital and 5% a dental
clinic. Out of a total of 82 children with BL, only 8 were
correctly diagnosed with a tumor at the initial entry node
of care, 7 (11%) in Uganda and 1 (5%) in Kenya. The
remainder of children were either misdiagnosed or not
informed of a diagnosis at this first encounter.
The majority of guardians in both Kenya and Uganda
visited multiple nodes of care before reaching JTRH or
UCI, with guardians in Uganda accessing a greater num-
ber on average than those in Kenya. In Uganda, 20% of
the guardians reached UCI at the 3rd node of care,
28% at the 4th node, 33% at the 5th node, and 20% at
the 6th node of care, or thereafter (median 5th node of
care, range 3–16). In contrast, 15% of guardians in Kenya
reached the care endpoint, JTRH, at the 2nd node of care,
50% at the 3rd node, 30% at the 4th node, and 5% at the
6th node of care (median 3rd node of care, range 2–6).
A key distinction between our catchment sites is that
UCI serves as a national referral hospital while JTRH is
a regional referral center. The geographic areas served
by the respective hospitals were roughly equal in size as
Kenya is almost twice the size of Uganda, however this
could have contributed to the greater number of refer-
rals in Uganda compared to Kenya.
Most common misdiagnoses across all nodes of care
in both settings were dental problem/cyst, splenomegaly/
abdominal swelling, malaria and non-malarial infection.
In Uganda, dental problem/cyst was the most frequent
Table 1 Demographic and socio-economic characteristics
of the guardians of children with Burkitt lymphoma at
Jaramogi Oginga Odinga Teaching and Referral Hospital
(JTRH) and Uganda Cancer Institute (UCI), 2010
Western Kenya,
n (%)
Uganda,
n (%)
Total 20 (100.0) 62 (100.0)
Guardian
Mother 16 (80.0) 31 (50.0)
Father 2 (10.0) 12 (19.4)
Grandparent 0 (0) 12 (19.4)
Aunt 1 (5.0) 3 (4.8)
Sibling 1 (5.0) 3 (4.8)
Self 0 (0) 1 (1.6)
Age (years) Mean 36.3
(range 22–60)
Mean 39.3
(range 22–65)a
Primary Caretaker
Yes 18 (90.0) 56 (90.3)
No 2 (10.0) 6 (9.7)
Number of children in household
1-2 4 (20.0) 12 (20.0)
3-4 8 (40.0) 20 (33.3)
≥ 5 8 (40.0) 28 (45.2)
Education
Did not complete primary
education
8 (40.0) 38 (61.3)
Completed primary
education
6 (30.0) 9 (14.5)
Attended secondary
education
1 (5) 6 (9.7)
Completed secondary
education
5 (25) 4 (6.5)
Other 0 (0) 5 (8.1)
Occupation
Peasant farmer 10 (50.0) 42 (67.7)
Self-employed/Small
business
6 (30.0) 8 (12.9)
Other 4 (20.0) 12 (19.4)
Religion
Christianity 20 (100.0) 52 (83.9)
Pentecostal 10 (50.0) 13 (21.0)
Catholic 4 (20.0) 22 (35.5)
Anglican 3 (15.0) 13 (21.0)
Seventh Day Adventist 1 (5.0) 4 (6.5)
Other 2 (10.0) 0 (0)
Islam 0 (0) 1 (1.6)
None 0 (0) 9 (14.5)
Table 1 Demographic and socio-economic characteristics
of the guardians of children with Burkitt lymphoma at
Jaramogi Oginga Odinga Teaching and Referral Hospital
(JTRH) and Uganda Cancer Institute (UCI), 2010
(Continued)
Language of the Interview Duoluo – 15 (75.0) Lugandan – 55 (88.7)
Swahili – 3 (15.0) Multiple – 2 (3.2)
English – 2 (10.0) English – 5 (8.1)
a9 missing or unknown.
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misdiagnosis (observed in 19 encounters), followed by
non-malaria infection (n = 11), splenomegaly/abdominal
swelling (n = 7) and malaria (n = 7). In Kenya, most com-
mon misdiagnoses were splenomegaly/abdominal swelling
(n = 10) and malaria (n = 8). Data on treatment were
available for only the first three health encounters in
both settings. We examined most common treatments
prescribed for those encounters that did not yield a tumor
diagnosis—a grouping that includes misdiagnoses and
encounters in which guardians were not informed of a
diagnosis. Out of a total of 119 encounters meeting this
criteria in Uganda, guardians most frequently reported
receiving unspecified injections/tablets/ointments—as
documented in 70 encounters (59%), followed by no
treatment—23 encounters (19%). Of note, 16 encounters
(13%) resulted in tooth extractions in this setting. Other
common treatments reported include: pain medication/
analgesics (n = 12, 10%), antibiotics (n = 10, 8%), and eye
drops/ointment (n = 5, 4%). This is in contrast to Kenya,
where slightly different treatment practices were observed.
Of the 37 health encounters in this setting, guardians
were most likely to receive no treatment—as reported in
12 cases (32%), followed by anti-malarials (n = 9, 24%),
pain medication (n = 6, 16%) and antibiotics (n = 5, 14%).
No Kenyan guardians reported tooth extractions prior
to arriving at JTRH.
Source of referrals to JTRH and UCI are presented in
Table 2. Forty-percent of all guardians learned about JTRH
from health centers (any level), with the remainder referred
from: dispensaries (15%), dental clinics (15%), friends/
neighbors/self (15%), and private/mission hospitals (10%).
In Uganda, almost all guardians (81%) arrived at UCI
after referral from Mulago Hospital, the Uganda National
Referral Hospital located on the same campus as UCI.
Given the proximity and affiliation of these centers, we
considered referral sources as the last node of care prior
to Mulago Hospital or UCI for those referred directly from
lower-level facilities. Most common referral sources were
district hospitals (32%), regional hospitals (24%), private/
mission hospitals (24%) and health centers (any level, 8%).
Structural factors influencing access to care
Nearly all guardians in Kenya and Uganda relied on
public transportation to reach the cancer referral cen-
ters, as shown in Table 3. Reported transportation costs
to UCI and JTRH were considerable, as was travel time;
both of which were found to be slightly higher in Uganda
than Kenya. The median cost of transport in Uganda
was USD $4.47 (range 0.45-89.44) and the median time
to reach UCI was 4 hours (range 0.5-27 hours). In Kenya,
guardians paid a median of $3.41 (range 0.37-8.69) and
traveled for 2.5 hours (range 0.3-5).
Guardians accompanying the children with BL were
all family members and most were the primary caretakers.
Many perceived household obligations, including care of
their other children, as a major obstacle to seeking care
for their ill child. A considerable proportion indicated that
no one else was able to bring the child to the hospital
(Kenya 35%, Uganda 52%); however, most received some
level of instrumental support from family members. About
three-quarters in Kenya and Uganda relied on adult family
members to care for other children at home; another
quarter relied on older children in the household. Notably,
only one guardian in either setting received support in the
form of childcare from the community.
Knowledge and concepts concerning disease
Knowledge of childhood cancer in general and BL in
particular was limited among participants at JTRH and
UCI (Table 4). None of the guardians in Kenya had ever
known a child with cancer and few (16%) in Uganda had.
Only a small minority - 5% and 19% in Kenya and Uganda,
respectively were aware that children could get cancer and
even fewer had ever heard of BL (5% both sites). When
questioned more broadly on general knowledge and per-
ceptions of cancer, most were uncertain if it was curable
(Kenya 65%, Uganda 53%). About 20% of all guardians in
Uganda agreed, “cancer is contagious,” with 67% undecided
on the matter. In contrast, in Kenya, nearly all (90%) dis-
agreed or strongly disagreed with the statement. Stigma
associated with cancer was more commonly reported in
Uganda than Kenya. Sixty-percent in Uganda felt cancer
was stigmatized in their communities; only 20% of guard-
ians in Kenya felt similarly. Overall, guardians in this study
did not perceive cancer as a curse or a bewitchment, with
most disagreeing when asked directly, as shown in Table 4.
Table 2 Most frequent sources of referrals to Jaramogi
Oginga Odinga Teaching and Referral Hospital (JTRH)
and Uganda Cancer Institute (UCI) for children presenting
with Burkitt lymphoma, 2010
Western Kenya
(n = 20)
Uganda
(n = 61) a, b
NPGH/UCI referral source:
Regional Hospital 0 (0) 15 (24.2)
District Hospital 0 (0) 20 (32.3)
Health Center (any) 8 (40.0) 5 (8.0)
Private/Mission 2 (10.0) 15 (24.2)
Dispensary 3 (15.0) 0 (0)
Dental Clinic 3 (15.0) 3 (4.8)
Friend/Neighbor/Self 3 (15.0) 1 (1.6)
Traditional healer/herbalist 0 (0) 2 (3.2)
N/A 1 (5.0) c 0 (0)
aN = 61; 1 missing source of referral.
bFor the purposes of this analysis, UCI and Mulago was considered a single
node of care.
c1 patient diagnosed during routine care visit.
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Barriers to care: Guardians’ perceptions
The majority of guardians in this study identified financial
constraints as the major impediment to bringing their
child to the hospital (Kenya 70%, Uganda 89%). In some
cases this was described in terms of cost of transportation
and others as cost of care (i.e. user fees, diagnostics and
treatment). Consistent with these responses, the leading
response given for what would make coming to the hos-
pital easier was money. In Kenya, many also indicated
provision of transportation, which most likely relates to
financial costs as nearly all guardians in this setting—as
well as Uganda—relied on public transportation. Household
Table 3 Structural factors influencing access to cancer care for children with Burkitt lymphoma at Jaramogi Oginga
Odinga Teaching and Referral Hospital (JTRH) and Uganda Cancer Institute (UCI), 2010
Western Kenya, n (%) Uganda, n (%)
Region Nyanza −18 (90) Central – 27 (43.6)
Western – 2 [10] Eastern – 26 (41.9)
North East – 1 (1.6)
Southern – 1 (1.6)
Western – 7 (11.3)
Travel time to UCI/JTRH (hrs)
Mean (SD) 3.0 (0.3) 5.8 (0.8)
Median (range) 2.5 (0.3-5) 4 (0.5-27)
Transport to UCI/JTRH
Public transport 19 (95.0) 60 (96.8)
Personal/friend’s transportation 1 (5.0) 1 (1.6)
Mission or NGO vehicle 0 (0) 1 (1.6)
Travel cost to UCI/JTRH from home (USD)
Mean (SD) 3.91 (0.6) 6.68 (1.43)
Median (range) 3.41 (0.37-8.69) 4.47 (0.45-89.44)
Anyone else available to bring child to hospital (at admission):
No 7 (35) 32 (51.6)
Yes 13 (65) 29 (46.8)
Support; caring for other young children
Adult family member 13 (65.0) 46 (74.2)
Neighbor/friend in my home area 0 (0) 1 (1.6)
Older children 4 (20.0) 14 (22.6)
No young children in need of care 3 (15.0) 0 (0)
Perceived barriers to bringing child to the hospitala,b
Money 14 (70.0) 55 (88.7)
Household responsibilitiesc 6 (30.0) 13 (21.0)
Caretaker ill 0 (0) 2 (3.2)
Health system: communication issues, delay in diagnosis or transfer 1 (5.0) 10 (16.1)
Other 2 (10.0) 2 (3.2)
None 2 (10.0) 0 (0)
What would make coming to the hospital easierb,d
Money 12 (60.0) 55 (83.3)
Transport 11 (55.0) 0 (0)
Health system: improved communication, earlier diagnosis 0 (0) 6 (9.1)
Other 4 (20.0) 1 (1.5)
aKenya, 4 missing; Uganda, 3 missing.
bMore than one applicable; percentages add to greater than 100%.
cIncludes care of children, family members, and other non-specified household responsibilities.
dKenya, 2 missing; Uganda, 7 missing.
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responsibilities, as discussed above, were the second most
common response given as a barrier to care after costs,
as reported by approximately a quarter of participants
in both Kenya and Uganda. For some this was described
as responsibilities related to caring for other children
or ill family members, and others as unspecified house-
hold duties.
Factors associated with delay: univariate analysis
In this study, we sought to identify independent predic-
tors of total delay, guardian delay and health system delay
(Table 5). Factors that were examined include guardian
sociodemographic characteristics and knowledge of and
attitudes toward cancer, structural factors of healthcare
access, symptoms at illness onset and first node of care.
Among Kenyan guardians, the following factors were
found to be associated with delay: source of income,
region and the presence of bleeding gums or loose or
painful teeth at onset of illness. Both total delay and health
system delay were significantly greater among guardians
who identified as self-employed or small-scale business
owners as compared to those who were peasant farmers
Table 4 Guardian’s knowledge and perceptions of cancer, childhood cancer, and Burkitt lymphoma
Kenya, n (%) Uganda, n (%)
Cancer is contagious
Strongly agree 0 (0) 2 (3.2)
Agree 1 (5.0) 10 (16.1)
Undecided 1 (5.0) 39 (62.9)
Disagree 17 (85.0) 11 (17.7)
Strongly disagree 1 (5.0) 0 (0)
Cancer is a cursea
Strongly agree 0 (0) 1 (1.6)
Agree 1 (5.0) 6 (9.7)
Undecided 1 (5.0) 23 (37.1)
Disagree 17 (89.5) 32 (51.6)
Strongly disagree 0 (0) 0 (0)
Cancer is a bewitchmentb
Strongly agree 0 (0) 0 (0)
Agree 1 (5.0) 2 (3.2)
Undecided 0 (0) 17 (27.4)
Disagree 19 (95.0) 43 (69.4)
Strongly disagree 0 (0) 0 (0)
Cancer is curable
Strongly agree 0 (0) 2 (3.2)
Agree 7 (35.0) 22 (35.5)
Undecided 13 (65.0) 33 (53.2)
Disagree 0 (0) 5 (8.1)
Strongly disagree 0 (0) 0 (0)
Did you know that children can get cancer?
No 19 (95.0) 48 (77.4)
Yes 1 (5.0) 12 (19.4)
Have you ever known a child who has had cancer?
No 20 (100.0) 45 (72.6)
Yes 0 (0) 10 (9.7)
Have you ever heard of BL?
No 19 (95.0) 56 (90.3)
Yes 1 (5.0) 3 (4.8)
aDefined as a result of you doing something wrong.
bDefined as a result of someone doing a wrong to you.
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Table 5 Univariate analysis of association between sociodemographic and health-system variables and diagnosis delay among children with Burkitt Lymphoma in
Jaramogi Oginga Odinga Teaching and Referral Hospital (JTRH) and Uganda Cancer Institute (UCI), 2010
Kenya Uganda Pooled – Uganda and Kenya
Guardian delaya Health system delayb Total delayc Guardian delaya,d Health system delayb,d Total delayc,e Total delayc,f
Mean P Mean P Mean P Mean P Mean P Mean P Mean P
Overall 34.0 – 4.3 – 38.3 – 16.9 – 5.1 – 20.4 – 25.0 –
Guardian
Mother 38.1 0.58 4.7 0.28 42.8 0.62 17.7 0.62 4.3 0.59 22.4 0.28 29.7 0.74
Father 7.8 1.4 9.1 4.6 7.1 17.4 16.2
Grandparent - - - 16.3 4.0 16.4 16.4
Aunt 10.1 2.0 12.1 96.5 6.3 45.7 37.3
Sibling 44.1 7.3 51.4 2.0 2.3 3.9 15.8
Self - - - 4.2 13.0 17.1 17.1
Age (years)
<30 44.9 0.61 3.1 0.82 48.1 0.70 22.8 0.25 2.9 0.63 16.7 0.20 26.5 0.29
30 - 39 43.9 4.5 48.3 3.9 5.3 18.7 29.4
>39 - 49 8.8 5.7 14.5 9.3 7.1 17.5 16.7
>49 16.3 2.0 18.3 29.6 4.7 26.5 26.1
Primary
Caretaker
Yes 34.7 0.21 4.3 0.53 39.0 0.31 18.1 0.34 5.4 0.34 21.8 0.02 26.1 0.13
No 27.1 4.6 31.8 2.6 1.6 5.5 13.0
Education
Incomplete primary 8.6 0.65 5.7 0.80 14.3 0.76 16.5 0.06 5.1 0.11 20.7 0.12 19.5 0.25
Complete primary 87.9 3.1 91.0 22.0 0.8 24.1 52.8
Attended secondary 9.8 4.4 14.3 1.2 6.1 10.5 11.0
Completed secondary 14.7 3.6 18.3 34.5 9.8 40.7 28.3
Occupation
Peasant farmer 7.1 0.11 2.1 0.01 9.2 0.05 17.2 0.06 4.9 0.99 21.0 0.33 18.6 0.09
Self employed/business 66.2 9.1 75.3 49.5 4.1 28.1 48.4
Other 52.9 2.6 55.5 8.1 5.9 13.5 24.0
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Table 5 Univariate analysis of association between sociodemographic and health-system variables and diagnosis delay among children with Burkitt Lymphoma in
Jaramogi Oginga Odinga Teaching and Referral Hospital (JTRH) and Uganda Cancer Institute (UCI), 2010 (Continued)
Number of children
0-2 55.7 0.74 2.6 0.47 58.3 0.79 4.6 0.26 2.4 0.25 9.2 0.03 21.5 0.11
3-5 34.6 3.5 38.1 12.4 7.2 20.7 26.0
≥ 6 10.2 8.6 18.9 33.9 4.7 26.9 25.5
Care node of first entry
Regional Hospital 298.0 0.50 10.6 0.76 308.6 0.53 3.0 0.28 1.1 0.06 18.1 0.69 76.2 0.79
District hospital 9.4 2.6 12.0 85.7 4.3 46.6 39.7
Health center (any) 4.4 5.3 9.6 4.9 8.0 18.4 17.8
Private/Mission 15.4 11.6 27.0 14.0 4.0 16.9 18.2
Dental Clinic 199.4 2.0 201.4 3.0 15.7 13.9 60.8
Mobile Clinic 10.0 3.2 13.2 - - - 13.2
Community Clinic 9.4 3.4 12.9 - - - 12.9
Dispensary 9.9 2.9 12.8 - - - 12.8
Other - - - 10.9 2.0 27.6 27.6
Care Nodes (#)
0-2 13.1 0.98 10.2 0.69 23.3 0.93 - N/A - N/A - 0.15 23.3 0.29
3-4 39.4 3.3 42.8 16.9 5.1 22.6 29.9
5-6 9.4 2.6 12.0 - - 15.9 15.7
>6 - - - - 29.3 29.3
Referral Source
Regional Hospital - 0.82 - 0.89 - 0.97 18.8 0.60 5.1 0.53 21.1 0.74 21.1 0.98
District Hospital 13.4 3.1 16.5 8.1 9.1 20.4 17.8
Health Center (any) 8.9 2.0 10.9 - - - 10.9
Private/Mission 71.1 3.3 74.4 1.4 2.9 16.3 38.0
Dental Clinic - - - 7.6 1.0 8.6 8.6
Friend/Neighbor/Self 15.4 11.0 26.4 - - - 26.4
Other 62.1 5.1 67.3 - - - 67.3
Travel time (hours)
0 - 2 37.3 0.66 5.1 0.65 42.3 0.60 29.6 0.33 2.6 0.19 20.1 0.39 29.3 0.60
>2 - 4 8.3 3.2 11.5 19.7 6.0 28.6 25.1
>4 - 8 53.0 4.0 57.0 4.9 6.7 13.8 22.4
>8 - - - 15.0 3.6 17.7 17.7
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Table 5 Univariate analysis of association between sociodemographic and health-system variables and diagnosis delay among children with Burkitt Lymphoma in
Jaramogi Oginga Odinga Teaching and Referral Hospital (JTRH) and Uganda Cancer Institute (UCI), 2010 (Continued)
Transport
Public Transport 35.3 0.79 4.3 0.54 39.6 0.66 16.9 N/A 5.1 N/A 21.1 0.62 25.8 0.65
Personal/friend’s 9.8 4.4 14.3 - - 10.7 12.5
Mission or NGO - - - - - 8.6 8.6
Travel cost
0 – 2.49 46.2 0.37 5.6 0.59 51.7 0.38 23.6 0.30 3.7 0.26 24.3 0.72 35.1 0.32
2.50 – 5.00 46.3 2.7 48.9 8.4 3.5 19.4 25.8
5.01 – 7.50 4.9 2.8 7.7 3.3 4.2 15.0 12.9
>7.50 8.6 8.6 17.1 21.7 7.7 22.4 22.1
aMean interval between onset of clinical symptoms and first encounter with health care system.
bMean interval between first encounter with health care system and initiation of treatment at UCI/NPGH.
cMean duration of clinical symptoms on presentation at UGI/NPGH.
dData available for those guardians with 4 or less care nodes in total; n = 26.
eN = 59, 3 missing.
fN = 79 (Kenya, n = 20; Uganda, n = 59), 3 missing.
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and other occupations (Kruskal-Wallis, p = 0.01 and 0.05,
respectively). The sample size was too small to draw any
conclusions from comparison from findings related to
region and initial symptoms. All but two guardians were
from the Nyanza region and only two children initially
experienced bleeding gums or loose or painful teeth. None
of the other factors investigated emerged as predictors
of delay—guardian delay, health system delay, total delay—
in this setting.
In Uganda, guardian delay was influenced by beliefs
about the curability of cancer, with delay being paradoxic-
ally greater among those who believed cancer is curable
(Spearman, p = 0.04). Guardians’ perceptions of cancer
as a contagious disease, measured by Likert Scale, were
shown to be significantly associated with health system
delay in this setting; however, we were unable to identify
any meaningful trends in delay across the scaled responses
(Spearman, p = 0.04). There was a trend of increased total
delay with increased numbers of children in the house-
hold (Kruskal-Wallis, p = 0.03). Total delay was also
significantly greater among guardians who identified as
primary caretakers as compared to those who did not
(Wilcoxon rank sum, p = 0.02). Notably, other guardian
sociodemographic characteristics, structural factors of
healthcare access, symptoms at illness onset and loca-
tion of first health encounter did not influence delay at
this site. We also investigated factors associated with
delay in a pooled analysis of all guardians from both sites.
Interestingly, none of the variables examined showed an
independent association.
Discussion
Our study is one among a small number of studies address-
ing delays in diagnosis and treatment of childhood cancers
in low- and middle-income countries (LMIC). We identi-
fied 5 earlier studies, 2 of which focused on leukemia, 1
on retinoblastoma and 2 on all childhood cancers [11-14].
To our knowledge, our study is the first that focuses
exclusively on diagnosis delays among children with BL,
which is a physically evident disease and therefore easier
to detect by untrained parents. In both Kenya and Uganda,
we observed long delays from onset of symptoms to first
treatment, with the median total delay about 12 weeks in
both settings. In comparison, a recent meta-analysis that
pooled data on time to diagnosis among Non-Hodgkin
Lymphoma patients in HICs (n = 1081) reported a median
total delay of 3.8 weeks [15]. Findings from the earlier
studies addressing delays in diagnosis in LMIC were varied.
Median total delays were 4.1 and 4.4 weeks for leukemia,
15 weeks for retinoblastoma, and 4.9 and 13.1 weeks for
studies including all childhood cancers. Of note, Brown et al.
reported results on delay in Nigeria stratified by diagno-
sis and found median delay among children with BL was
9.7 weeks, slightly shorter than present findings [11].
In both of our study populations, guardian delay con-
stituted the majority of the total delay—74% in Kenya
and 65% in Uganda. Median health system delay was
2 weeks in Kenya and 2.6 weeks in Uganda, Length of
health system delay at both sites was comparable to
data from earlier studies on delays for other childhood
cancers in LMIC: in Nicaragua (2 weeks) and South Africa
(3 weeks), although less than delays observed in Nigeria
(9 weeks) [11,13,14]. In contrast, guardian delay in the
present study was considerably longer than previous
reports—9 weeks in Kenya and 4.6 weeks in Uganda as
compared to 1 to 2 weeks in other LMIC settings studied
[11,13,14]. Overall, our findings differ from those previ-
ously reported, which have shown a tendency for guardian
delay to be less than health system delay, both in LMIC
and HIC [11,13,14,16].
The long guardian delay in our study may reflect
guardians’ perceptions of illness, misinterpretation of early
symptoms, poor access to health care facilities (distance
and transportation availability and financial constraints)
and competing household and work responsibilities. Al-
though delays in diagnosis appear to be largely due to
guardian delay in our study population, we also observed
considerable variation in delay among respondents. That
is, health system delay emerged as the main component
of total delay for many—15% in Kenya and 42% in Uganda.
Across both settings, guardians reported multiple care
nodes and complex and indirect pathways of navigation.
Prolonged health system delay in these cases and others
may be partially explained by limited knowledge of BL
among health service providers, insufficient clinical in-
vestigations or failure to refer patients to heath facilities
with resources for further management. Another im-
portant consideration is the limitations of the guardian
delay versus health system delay dichotomy. This con-
struct establishes two separate time intervals to attempt
to isolate and examine delay that may be explained by
guardian-level factors separately from that which may
be attributable to the health system. This framework relies
on the false assumption that there is no interplay between
these factors. That is, it implies that after a child reaches
the first health facility, the care-seeking experience is
essentially sheltered from guardian-level influences like
region, cost and availability of transportation and health
beliefs. The limitations of this construct become most
apparent in the context of multiple visits to care facil-
ities as many of the same factors influencing guardian
delay may contribute to delays in pursuing follow up
care. Additional studies would be necessary to disen-
tangle the longitudinal contribution of these elements.
Few of the factors investigated were found to be associ-
ated with guardian delay or health system delay in Kenya
and Uganda. Many of the guardian socio-demographic
characteristics did not influence delays in either settings,
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including age, education, occupation and select indicators
of socioeconomic status (housing, windows, home cooking
apparatus, water source and animals in home). Past re-
search that has examined the influence of education on
diagnosis delay in childhood cancers has been inconsist-
ent. Several studies in LMIC and HIC have shown shorter
total delay [16,17] and guardian delay [12,18,19] with in-
creased levels of education, yet other studies—conducted
in Nigeria and South Africa—have found education to
have no significant effect [11,14]. With few respondents
reporting education beyond primary school, it is possible
our study population was too homogenous to discern any
significant association.
In Kenya, we found guardian’s relationship to the child
had no effect on delay. However, in Uganda, total delay
was found to be greater among those who identified as
primary caretaker as compared to those who did not. These
findings may reflect the influence of several factors on
primary caretakers and their access to care, including
household and work obligations and the availability of
social support. The benefit of social resources, from family
and/or friends, in overcoming barriers to healthcare utili-
zation has been well characterized throughout the litera-
ture [20]. In the present study, support largely came from
other family members rather than the community, with
nearly all guardians reporting shifting roles among fam-
ilies as a consequence of the child’s illness.
Interestingly, there was no association between select
indicators of socioeconomic status and delay in either
Kenya or Uganda. Structural factors including travel time
and costs of transportation to the JTRH and UCI also
did not emerge as independent predictors of delay in
our analysis. Our results contradict previous studies in
Kenya and Uganda, which have shown reduced access
to and utilization of health services among lower socio-
economic groups, with distance to the facility and costs
of care among the key barriers [20-23]. These earlier
findings are supported in our study, however, by guard-
ians’ perceptions of the barriers to care. When asked
what was most difficult about bringing the child to the
hospital, financial issues were the leading concern, often
related to costs of transportation and clinical care. Many
of the guardians traveled long distances to reach JTRH
and UCI and nearly all used public transportation. Travel
time and transportation costs were particularly high in
Uganda, where UCI serves a broader catchment area as
the national cancer referral center; JTRH in contrast is
one of several regional cancer referral centers in Kenya.
In both of these settings, guardians reported multiple
health encounters prior to JTRH and UCI, resulting in
accumulating costs, of travel, user fees, diagnostic tests
and treatment, none of which were assessed in the present
study. Thus, it is conceivable that measured costs were
too narrow in scope to observe any correlation. Future
studies should explore the impact of these additional
costs on delay, as well as indirect costs such as loss of
daily income.
Our results related to guardians’ knowledge of cancer
indicate low awareness of cancer among the general com-
munity. Interestingly, however, knowledge of cancer or
specifically BL did not appear to influence delay in either
setting. This suggests interventions aimed solely at in-
creasing disease awareness may be insufficient for im-
proving early diagnosis. Also evident from these findings
is that guardians arrive at UCI and JTRH with a limited
understanding of their child’s illness despite multiple
encounters within the health care delivery system leading
up to admission to the cancer center. This may partially
reflect the fact that many children remained undiagnosed
or were misdiagnosed at lower-level facilities; however,
insufficient communication between health providers and
guardians may also be a contributing factor.
Perceptions of cancer were largely similar among guard-
ians in Kenya and Uganda. Few thought cancer was conta-
gious or viewed the illness as a curse or a bewitchment.
One exception was stigma, which was more common in
Uganda than Kenya. Although past studies have shown
stigma and fears of discrimination can be an important
barriers to care, these sentiments were not associated with
delay in the present study [24]. Overall, few guardians in
Uganda and Kenya perceived cancer as curable. In Uganda,
surprisingly, guardian delay was significantly greater
among those who did. We believe this may be a spurious
association, however, as few of these guardians (17%; 4
of 24) suspected their child’s illness was cancer before
seeking care. In both settings, misconceptions related to
the curability of BL have important implications for
efforts to improve early diagnosis. Guardians who learn
or suspect their child has cancer may be less likely to
utilize health services if they perceive treatment will have
little to no benefit [25]. Understanding that BL is a curable
illness provides hope and reason to pursue care.
Earlier research has shown that initial presentation of
symptoms can influence time to diagnosis for other
malignancies, including retinoblastoma, brain tumors and
leukemia [12,16,17,26]. In the present study, we found no
difference in delay according to early symptoms or guard-
ians’ interpretations of the symptoms. These findings may
be attributable to the non-specific symptoms observed in
early BL. This non-specific presentation, and BL’s relative
rarity, underscores the inherent challenges of timely diag-
nosis of this disease. Symptoms common to many condi-
tions can lead not only to varying perceptions of illness
among guardians, but also frequent misdiagnosis in clin-
ical settings. An example in malaria holoendemic areas
where splenomegaly is common would be the misdiag-
nosis of an abdominal tumor located on the left side as
opposed to the right side of the body.
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Guardians in both settings experienced lengthy health-
seeking itineraries, often consisting of several different
types of health facilities. Guardians most commonly first
sought care in Uganda at private clinics, and in Kenya,
at dispensaries; about half visited other care providers.
Notably, almost all guardians reported that they first sought
western medicine and not care from traditional healers.
It is possible however that use of alternative forms of
care such as traditional medicine may be underreported
due to perceived stigma. Although various levels of health
facilities typically differ in their human resources and
institutional capacities, there were no significant differ-
ences in delay according to the first point of care. Brown
et al. reported similar results related to total delay, but
found increased guardian delay at tertiary care centers
when compared to lower-level facilities [11]. Many of the
health encounters in our study resulted in sub-optimal
care, including misdiagnoses and inappropriate treatment,
particularly at lower-level facilities. We examined treat-
ment practices across various levels of the health system
however data were insufficient to identify any trends.
Future studies should explore this relationship as any
findings may yield valuable information for improving
care delivery. Overall, our results suggest that interven-
tions designed to address diagnosis delays should include
outreach and continuing education for health profes-
sionals across multiple levels of the health system. Local
providers must be able to recognize early signs of cancer
and make appropriate referrals and adequately commu-
nicate the need for haste to the parents.
An earlier study on guardians’ perspectives of barriers
to pediatric cancer care was conducted at UCI in 2007,
three years prior to our study (K. Stiffler, University of
Washington School of Public Health Masters thesis). A
similar survey was administered to 32 guardians of chil-
dren with cancer on arrival to UCI; 23 of the children
were diagnosed with BL. Comparison of findings from
the two studies yields interesting insight into possible
changes in health-seeking behaviors among guardians in
Uganda, and their experiences navigating the health-
system for effective treatment.
Overall, the mean total delay, from onset of symptoms
to arrival at UCI, remained largely similar from 2007 to
2010 at 18.5 and 20.4 weeks, respectively. In contrast,
there was a shift in the main component of total delay,
from health system delay in 2007 to guardian delay in
2010. The mean health system delay decreased from 69%
of the total delay (12.9 weeks) in 2007 to 23% in 2010,
whereas the mean guardian delay increased from 31%
of the total delay (5.2 weeks) to 77%. This comparison
is limited by several factors, including slight differences
in study procedures and questionnaires, and missing 2010
data on guardian delay and health system delay, as discussed
previously. With data only available for guardians with 3
or less health encounters prior to UCI, it is possible that
2010 estimates of health system delay represent a slight
underestimation. Despite this limitation, the marked differ-
ence between these two estimates suggests that the time
to UCI after guardians first seek care may be decreasing.
One possible explanation may relate to differences in
the study population, with guardians from 2010 repre-
senting a slightly broader catchment area. Mean travel time
among this group was 5.8 hours as compared to 2.9 hours
in 2007. This could reflect increasing country-wide aware-
ness of cancer due to the collaboration between UCI and
the Fred Hutchinson Cancer Center and the formation of
The Uganda Program on Cancer and Infectious Disease
that has been receiving a lot of media attention. Both
studies identified transportation and financials costs as
the most important barriers to seeking care.
Many of the factors investigated in the present study,
including knowledge and attitudes toward cancer and
structural barriers to care, contribute not only to late
stage of presentation, but also refusal and abandonment
of therapy, one of the leading causes of poor outcomes
in resource-limited settings [27]. For example, in a recent
study on BL in Nigeria where parents were required to
pay for chemotherapy and laboratory diagnostics, only half
of all children presenting to the hospital completed treat-
ment due to financial constraints; 20% never initiated
treatment and another 32% abandoned treatment due to
costs [19]. Israëls et al. also reported similar findings
from a study on abandonment among guardians of chil-
dren with BL and Wilms tumor at a public hospital in
Malawi, where treatment is provided free of charge [28].
Factors influencing abandonment included financial costs
related to transportation, food and loss of income; house-
hold responsibilities; and perceptions related to the cur-
ability of cancer.
Our study has several limitations. The sample sizes in
both Kenya and Uganda were relatively small. Secondly,
all data were self-reported. Guardians were asked to re-
port on several variables across multiple health encoun-
ters that took place over an extended period of time.
Thus, recall bias is a concern. Perhaps most importantly,
our findings represent only those guardians who suc-
cessfully navigated the health system, received appropri-
ate referrals and arrived at the cancer centers, UCI and
JTRH, for treatment. Many other children with BL in both
settings may have been less fortunate and remained undiag-
nosed or mismanaged at lower-level facilities. Community-
based investigations of the health-seeking experiences
would provide additional insight into the barriers to diag-
nosis and treatment, including factors that may have not
been examined in the present tertiary care, hospital-based
setting.
Using guardian delay and health system delay to analyze
time intervals across the care-seeking experience also has
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several limitations. One source of bias stems from our
methods of measuring guardian delay, which relied on
questions of when symptoms were first recognized and
when care was first sought. Assessing symptom recogni-
tion and interpretation presents many difficulties that
have been well characterized throughout the literature
[29]. Although this discussion is beyond the scope of
this paper, it is important to note that our analysis relied
on the flawed assumption that all guardians recognize
and interpret symptoms in similar ways. A more compre-
hensive inquiry into guardians’ perceptions of symptoms
would provide a more accurate and precise assessment of
guardian delay. Lastly, many of the same factors influen-
cing guardian delay can influence health system delay,
particularly with multiple health encounters, as previously
discussed.
Conclusions
This study aimed to examine delays in the diagnosis and
treatment of children with BL in Uganda and western
Kenya, and to identify the factors that may contribute
to these delays. We found that prolonged delays are
common in both settings, with much of the delay occur-
ring prior to the first health encounter. Consistent with
earlier studies of other childhood cancers, we found that no
single factor emerged as a major cause of delay, but rather
a confluence of factors was implicated [11-14,16,18,30].
Among guardians, structural barriers emerged as the
leading concern, particularly those related to costs of
transportation and clinical care. Searching for an accurate
diagnosis and effective treatment was a resource-intensive
and complex endeavor for many guardians, requiring mul-
tiple visits to different health facilities and care providers.
During these visits, many children remained undiagnosed
or were inappropriately treated before reaching the cancer
referral centers.
Our findings related to mismanagement of BL cases
at lower level facilities highlights an important area of
weakness in the health system contributing to late stage
of presentation and poor outcomes among children with
BL and likely childhood cancers in general. In both Uganda
and western Kenya, recent efforts have been made to shift
cancer care modalities to lower level facilities to improve
access to care. We believe that our findings support the
argument that the best allocation of resources involves
continued development of strong centralized cancer cen-
ters with efficient referral systems. This notion is support
by a recent review of best-practice care models for na-
tional cancer plans [31].
Overall, our study suggests that multidimensional in-
terventions are likely required to address late stage of
presentation among children diagnosed with BL. Based
on our findings, we recommend that efforts aimed at re-
ducing delays in diagnosis consider the following actions;
1) Targeted health education of guardians on the import-
ance of seeking early care for children’s illnesses; 2) In-
crease awareness of childhood cancers among the general
public using effective means of communication; 3) Mini-
mize structural barriers to care; 4) Continuing education
programs for health providers on signs and symptoms
of common childhood cancers, including providers at
lower-level facilities; 5) Improve referral linkages between
community health providers and cancer referral centers.
Methods
Study design
This research study was designed to collect quantitative
and qualitative data from guardians of children diagnosed
with BL at major cancer referral centers in Uganda and
western Kenya through use of standardized question-
naires. The primary objectives of this study are to identify
barriers to prompt diagnosis and treatment of children
with BL in Uganda and western Kenya and to examine
the factors that influence the health-seeking behaviors
of guardians whose children have been diagnosed with
BL in these settings. The study was carried out at the
Jaramogi Oginga Odinga Teaching and Referral Hospital
(JTRH), formerly named the New Nyanza Provincial Gen-
eral Hospital, Kisumu, Kenya and Uganda Cancer Institute
(UCI), Kampala, Uganda. Enrollment was initiated in
January 2010 and continued through December 2010.
Study site and population
JTRH is a public regional referral hospital, which serves
as the referral center for children diagnosed with cancer
in western Kenya. It is located in an urban setting in
Kisumu, Kenya, the third largest city in the country. UCI
is a public referral comprehensive cancer center that is
adjacent to Makerere University College of Health Sciences
and Mulago hospital; it is the national referral center for
childhood cancer in Uganda. Kampala is the largest city in
Uganda. Guardians were eligible if their child was diag-
nosed with BL and admitted to JTRH or UCI for treat-
ment, and they were able and willing to give informed
consent. If more than one parent or guardian was present,
both were eligible to participate individually. Study partici-
pants were excluded if they spoke languages other than
those spoken by the study investigators or key personnel.
Recruitment
Staff at JTRH and UCI identified guardians eligible for
recruitment and invited them to participate in a research
questionnaire study. Potential study participants were
informed of the study details, read the consent form,
and provided the opportunity to ask questions, as well
as consult with other family members. Interested and
willing guardians were administered a short quiz to
assess understanding of study procedures. Informed consent
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was obtained from guardians who demonstrated an ad-
equate understanding—verbal consent in Kenya and writ-
ten consent in Uganda. Those with quiz performances
that suggested they did not understand the study and im-
plications of participation were excluded.
Data collection tools
We designed standardized questionnaires to be adminis-
tered to guardians as structured face-to-face interviews
during the child’s first or second treatment course. The
questionnaires were developed based on the conceptual
framework of the Health Belief Model [25] using infor-
mation gathered through semi-structured interviews of 8
key informants involved in the care of children with BL
at JTRH and UCI, which were conducted in June and
July 2008. Key informants included physicians, nurses,
and other supportive staff. During these interviews, we
sought to identify reasons for delayed diagnosis and treat-
ment of children with BL in Uganda and western Kenya.
The questionnaires were then beta-tested at JTRH and
UCI over a four-week period with guardians of children
who were diagnosed with BL and receiving care as in-
patients at the time. Questionnaires were then further
refined and prompts written after each question to clas-
sify type of response if ambiguity unavoidably remained
in translation.
The questionnaire collected information on the follow-
ing factors: demographics (e.g. home location, occupation,
schooling, religion, etc.), barriers to health care utilization
identified by the guardians (ex. distance to health care
center, cost of transport, inability to leave other children,
etc.), series of events leading up to the child’s arrival at the
study site including each provider and place where care
was sought and what diagnosis and treatment were given.
The questionnaire also assessed knowledge, attitudes and
health-seeking behaviors of the parent (e.g. use of trad-
itional healers or traditional medicines). Pertaining to atti-
tudes, we investigated beliefs about the curability of cancer
and perceptions of cancer as a curse or a bewitchment. We
also assessed conceptions of stigma associated with cancer
in the community using local terms for stigma and related
feelings of guilt and shame.
In Uganda, the questionnaires were translated from
English into Lugandan, the most commonly spoken lan-
guage in Uganda. In Kenya, the questionnaires were trans-
lated from English into Kiswahili (the second national
language) as well as into Dholuo (the language of the Luo
tribe, the most populous tribe in Nyanza province). Ques-
tionnaires and consent forms were back-translated into
English at both sites to verify the accuracy of the translations.
Data collection
Once participants were recruited and gave informed con-
sent, a trained member of study personnel administered
the questionnaire during the child’s first or second treatment
course by means of face-to-face interview as described
above. The questionnaire was read to all participants in their
preferred language irrespective of literacy, and responses
were recorded on the questionnaire form. Interpreters
were utilized for those guardians preferring languages
other than English or Lugandan (in Uganda), and English,
Kiswahili or Dholuo (in Kenya).
Definitions
Prior studies on delays in childhood cancer care have
utilized constructs to analyze time intervals across the
care-seeking experience. One common approach divides
the time lapsed for the entire care-seeking experience,
also referred to as “total delay,” into two subcomponents,
“guardian delay” and “health system delay” [14,16]. Total
delay, in the present study, is defined as the time interval
from the onset of disease-related symptoms to arrival at
JTRH /UCI for treatment; guardian delay, the time period
from recognition of symptoms to first encounter with
the healthcare system; and health system delay, the time
period from the first encounter with the health system
to arrival at JTRH /UCI for treatment. “Care node,” a
term originally introduced by Dye, et al., refers to sites
delivering health services, including all levels of facilities
and providers (ie. tertiary care centers, regional hospitals,
health centers, traditional healers/herbalists, etc.) [32].
Data processing and analysis
Data were entered into Microsoft Excel, reviewed for
consistency and completeness, and analyzed with the use
of STATA statistical software package 11.0 [33]. Categor-
ical variables were described with frequency distributions,
and continuous variables, with parametric tests. Compari-
sons of categorical variables between the two sites were
calculated with Chi-square test or Fisher’s exact test when
needed. Normality of continuous data was assessed using
the skewness-kurtosis test, which found the following to
be skewed: total delay, guardian delay, health system delay,
total care nodes, travel time to JTRH /UCI and transport
costs. Thus, comparisons related to these variables were
computed by non-parametric methods: The Wilcoxon rank
sum test and the Kruskal-Wallis test were employed for
comparisons of delay by different categorical variables
among each site. Analyses of delay across ordinal vari-
ables were carried out with the Spearman correlation.
For all tests, p < 0.05 was considered to be statistically
significant.
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